Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Molecular Biology Antibody-drug-conjugates

 Transparent impact polymers
OF THE INVENTION The monomers of the feed mixture of this invention are selected from three ...


 Oil reclaimer
I claim: 1. An apparatus for removing impurities from lubricating oil, comprising, a container ...


 Visual-type hygrometer
What is claimed is: 1. The complexes of the alkali metals salts of 3,3',4,4' benzophenone ...


 Plant watering indicator
I claim: 1. Apparatus for indicating when a plant requires to be watered comprising, a member ...


 Affinity detection apparatus
In the immunoassay apparatus disclosed herein, the coated member and well have complimentary shapes ...


 Sulfide containing tin stabilizers
What is claimed is: 1. A monoorganotin or diorganotin mercaptoalkyl ester of a carboxylic acid or ...


 Method for enzyme reutilization
OF THE INVENTION Waste materials containing cellulose which have previously been disclosed as ...


 Compounds that bind to digitalis receptor
What we claim is: 1. A C3-glycoside derivative of a 14.beta.-hydroxypregnane and having the formula:...


 Reticulated cellulose and methods and microorganisms for the production thereof
The present invention includes a reticulated bacterial cellulose product having novel properties. T...


 Glycopetide antibiotic PA-45052-B
OF THE INVENTION The present inventors found that the strain belonging to the genus Nocardia ...


 Antibody-drug conjugates

Details
Inventors: Barton, Russell L.; Guttman-Carlisle, Deborah L.; Koppel, Gary A.;
Assignee: Eli Lilly and Company (Indianapolis, IN)
Primary Examiner: Achutamurthy; Ponnathapura
Assistant Examiner:
Attorney, Agent or Firm: Gaylo; Paul J.

Immunoconjugates of antibodies or antigen-recognizing fragments of antibodies and monovalent cytotoxic drug derivatives make use of .beta.-alanine derived linkers wherein the antibody or fragment thereof is attached to the linker's carboxy group via an ester or amide group and the drug is attached through the linker's 2-position methylene group. Intermediates, compositions and methods of use also are provided.

DETAILED DESCRIPTION OF THE INVENTION The present invention pertains to novel immunoconjugates, intermediates thereto, pharmaceutical compositions and methods of use.
Throughout the present document, all temperatures are in degrees celsius.
All expressions of percentage, concentration and the like are in weight units, unless otherwise stated.
All references to concentrations and dosages of drug conjugates are in terms of the amount or concentration of the drug contained in the conjugate.
In the above formulae, the general and specific chemical terms used have their normal meanings in organic and, especially, amino acid chemistry.
For example, the term "C.
sub.
1 -C.
sub.
4 alkyl" refers to straight or branched aliphatic chains of 1-4 carbon atoms including methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, sec-butyl and tert-butyl.
The carboxy protecting groups of R.
sup.
4 and R.
sup.
7, when R.
sup.
7 is neither H nor an activating group, denote groups which generally are not found in final therapeutic conjugates, but which are intentionally introduced during a portion of the synthetic process to protect a group which otherwise might react in the course of chemical manipulations, and is then removed at a later stage of the synthesis.
Since compounds bearing such protecting groups are of importance primarily as chemical intermediates, their precise structure is not critical.
Numerous reactions are described in a number of standard works including for example, Protective Groups in Organic Chemistry, Plenum Press, (London and New York, 1973); Green, T.
W.
, et al.
(eds), Protective Groups in Organic Synthesis, Wiley (New York, 1981); and Schroeder, et al.
(eds.
), The Peptides, Vol.
I, Academic Press (London and New York, 1965).
Preferred R.
sup.
4 and R.
sup.
7 carboxy protecting groups include C.
sub.
1 -C.
sub.
4 alkyl, phenyl which maybe substituted, and benzyl which may be substituted.
The term "phenyl which may be substituted" denotes an unsubstituted or substituted phenyl residue, optionally having one or two substituents selected from halo (bromo, chloro, fluoro, and iodo), nitro, C



Related patents
  Monoclonal antibodies against metal chelates
We claim: 1. A monoclonal antibody which exhibits specificity for a complex comprising a chelating agent and a first metallic ion, the antibody having an association ...
  Preparation of cyclic carbonates using alkylammonium and tertiary amine catalysts
OF THE INVENTION According to the process of the invention, cyclic carbonates having five or six-membered rings are prepared from the reaction of 1,2- or 1,3-diols and ...
  Thrombin inhibitory new dihydroxybenzene ether derivatives
We claim: 1. An ether derivative of a dihydroxybenzene of the formula ##STR40## wherein the ether groups are either ortho- or meta- to one another; A is selected from ...
  Deer repellent device and method
What is claimed is: 1. A deer repellent assembly comprising: a 100 foot length of one-quarter inch diameter elongate flexible rope of a cotton and polyester solid braid ...
  Solid consumer product compositions containing small particle clyclodextrin complexes
What is claimed is: 1. Pharmaceutical composition comprising an effective amount of active/cyclodextrin inclusion complex with pharmaceutical agent selected from the ...
  Water-dispersible protein/polyurethane reaction product
OF THE INVENTION In the process of our invention the isocyanate-capped liquid polyurethane prepolymer acts as: (a) a solvent to dissolve the protein which is to be ...
  Polyurethane hydrogels having enhanced wetting rates
What we claim is: 1. A method of improving the wetting rate of a water swellable, lightly crosslinked hydrogel polymer which comprises contacting said polymer with a ...
  Solid, water-dispersible plastics precursors containing isocyanate groups, a process for the production of aqueous plastics dispersions using such plastics precursors
OF THE INVENTION The plastics precursors according to the present invention are produced by the methods known in polyurethane chemistry, i.e. by reacting organic ...
  Pharmaceutical composition containing bile acid sequestrant enclosed in a size-exclusion membrane
OF THE PREFERRED EMBODIMENT In describing the preferred embodiment, certain terminology will be utilized for the sake of clarity. It is intended that such terminology ...
  Process for the preparation of insecticidal, nematicidal and acaricidal 2-halo-3-substituted-5-arylpyrrole compounds
OF THE INVENTION One of the preferred embodiments of the present invention involves reacting a formula II substituted acetonitrile compound as described above with at ...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved